163 related articles for article (PubMed ID: 35737109)
1. Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.
Barschke P; Abu-Rumeileh S; Al Shweiki MHDR; Barba L; Paolini Paoletti F; Oeckl P; Steinacker P; Halbgebauer S; Gaetani L; Lewerenz J; Ludolph AC; Landwehrmeyer GB; Parnetti L; Otto M
J Neurol; 2022 Sep; 269(9):5136-5143. PubMed ID: 35737109
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's Disease.
Al Shweiki MR; Oeckl P; Pachollek A; Steinacker P; Barschke P; Halbgebauer S; Anderl-Straub S; Lewerenz J; Ludolph AC; Bernhard Landwehrmeyer G; Otto M
Mov Disord; 2021 Feb; 36(2):492-497. PubMed ID: 33006791
[TBL] [Abstract][Full Text] [Related]
3. Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob Disease.
Abu-Rumeileh S; Barschke P; Oeckl P; Baiardi S; Mammana A; Mastrangelo A; Al Shweiki MR; Steinacker P; Ladogana A; Capellari S; Otto M; Parchi P
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216166
[TBL] [Abstract][Full Text] [Related]
4. Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease.
Niemela V; Landtblom AM; Nyholm D; Kneider M; Constantinescu R; Paucar M; Svenningsson P; Abujrais S; Burman J; Shevchenko G; Bergquist J; Sundblom J
Mov Disord; 2021 Feb; 36(2):481-491. PubMed ID: 33247616
[TBL] [Abstract][Full Text] [Related]
5. Alterations in prodynorphin, proenkephalin, and GAD67 mRNA levels in the aged human putamen: correlation with Parkinson's disease.
Bäckman CM; Shan L; Zhang Y; Hoffer BJ; Tomac AC
J Neurosci Res; 2007 Mar; 85(4):798-804. PubMed ID: 17203488
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.
Wagner L; Björkqvist M; Lundh SH; Wolf R; Börgel A; Schlenzig D; Ludwig HH; Rahfeld JU; Leavitt B; Demuth HU; Petersén Å; von Hörsten S
J Neurochem; 2016 Jun; 137(5):820-37. PubMed ID: 27016395
[TBL] [Abstract][Full Text] [Related]
7. Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression.
Nikoshkov A; Drakenberg K; Wang X; Horvath MC; Keller E; Hurd YL
Proc Natl Acad Sci U S A; 2008 Jan; 105(2):786-91. PubMed ID: 18184800
[TBL] [Abstract][Full Text] [Related]
8. Aerobic exercise improves motor function and striatal MSNs-Erk/MAPK signaling in mice with 6-OHDA-induced Parkinson's disease.
Wang X; Wang Y; Chen J; Li J; Liu Y; Chen W
Exp Brain Res; 2022 Jun; 240(6):1713-1725. PubMed ID: 35384454
[TBL] [Abstract][Full Text] [Related]
9. The expression of proenkephalin and prodynorphin genes and the induction of c-fos gene by dopaminergic drugs are not altered in the straitum of MPTP-treated mice.
Ziolkowska B; Horn G; Kupsch A; Höllt V
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):151-64. PubMed ID: 8527000
[TBL] [Abstract][Full Text] [Related]
10. Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.
Bissonnette S; Vaillancourt M; Hébert SS; Drolet G; Samadi P
PLoS One; 2013; 8(9):e75099. PubMed ID: 24040390
[TBL] [Abstract][Full Text] [Related]
11. Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy.
Iadarola MJ; Mouradian MM
Brain Res; 1989 Feb; 479(2):397-401. PubMed ID: 2522341
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
Rodrigues FB; Byrne L; McColgan P; Robertson N; Tabrizi SJ; Leavitt BR; Zetterberg H; Wild EJ
J Neurochem; 2016 Oct; 139(1):22-5. PubMed ID: 27344050
[TBL] [Abstract][Full Text] [Related]
13. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders.
Zhu S; Bäckström D; Forsgren L; Trupp M
J Parkinsons Dis; 2022; 12(4):1169-1189. PubMed ID: 35253777
[TBL] [Abstract][Full Text] [Related]
15. L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.
Hanrieder J; Ljungdahl A; Fälth M; Mammo SE; Bergquist J; Andersson M
Mol Cell Proteomics; 2011 Oct; 10(10):M111.009308. PubMed ID: 21737418
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.
Caron NS; Haqqani AS; Sandhu A; Aly AE; Findlay Black H; Bone JN; McBride JL; Abulrob A; Stanimirovic D; Leavitt BR; Hayden MR
Brain Commun; 2022; 4(6):fcac309. PubMed ID: 36523269
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
18. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
Lowe AJ; Sjödin S; Rodrigues FB; Byrne LM; Blennow K; Tortelli R; Zetterberg H; Wild EJ
PLoS One; 2020; 15(8):e0233820. PubMed ID: 32804976
[TBL] [Abstract][Full Text] [Related]
20. Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity.
Gieryk A; Ziolkowska B; Solecki W; Kubik J; Przewlocki R
Psychopharmacology (Berl); 2010 Feb; 208(2):291-300. PubMed ID: 19997907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
